title: Cotrimoxazole-resistant Nocardia sclerokeratitis: effective therapy with fourth-generation fluoroquinolones.
authors.forename: Vaibhev
authors.initials: V
authors.lastname: Mittal
authors.forename: Merle
authors.initials: M
authors.lastname: Fernandes
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001372:Aza Compounds / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D024841:Fluoroquinolones / Q000627:therapeutic use; D000077734:Gatifloxacin; D006801:Humans; D007634:Keratitis / Q000188:drug therapy* / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D000077266:Moxifloxacin; D009615:Nocardia / Q000187:drug effects / Q000302:isolation & purification; D009617:Nocardia Infections / Q000188:drug therapy* / Q000382:microbiology; D011804:Quinolines / Q000627:therapeutic use; D015423:Scleritis / Q000188:drug therapy* / Q000382:microbiology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000077734:Gatifloxacin; D000077266:Moxifloxacin